Michael William Bickell, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 225, Langhorne, PA 19047 Phone: 215-710-4490 Fax: 215-710-4491 |
Dr. Jamison S Jaffe, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 225, Langhorne, PA 19047 Phone: 215-710-4490 Fax: 215-710-4491 |
Dr. Sean T Mcginley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 225, Langhorne, PA 19047 Phone: 215-710-4490 Fax: 215-710-4491 |
Alan I Snyder, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1205 Langhorne Newtown Rd, Suite 104, Langhorne, PA 19047 Phone: 215-752-6931 Fax: 215-757-2195 |
Chanchi Lee, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 310 Middletown Blvd, Suite 200, Langhorne, PA 19047 Phone: 215-750-6510 Fax: 215-741-6322 |
Drew Hecht, D.O. Urology Medicare: Medicare Enrolled Practice Location: 310 Middletown Blvd, Suite 200, Langhorne, PA 19047 Phone: 215-750-6510 Fax: 215-741-1985 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced 10 new or updated software packages to help customers harness the power of its new-generation liquid chromatography-mass spectrometry (LC-MS) instruments and turn data into knowledge in a wide range of discovery and quantitation experiments.
The major innovations in cancer diagnosis, therapy/palliative care and surgical intervention are too numerous to list here. But enormous strides have taken place in stem cell therapy, monoclonal antibody therapy and genetic screening.
Johns Hopkins researchers report that the deletion of any single gene in yeast cells puts pressure on the organism's genome to compensate, leading to a mutation in another gene. Their discovery, which is likely applicable to human genetics because of the way DNA is conserved across species, could have significant consequences for the way genetic analysis is done in cancer and other areas of research, they say.
The first ever WHO Model Formulary for Children released by the WHO provides information on how to use over 240 essential medicines for treating illness and disease in children from 0 to 12 years of age. This means that for the first time medical practitioners worldwide have access to standardized information on the recommended use, dosage, adverse effects, and contraindications of these medicines for use in children.
Plant Bioscience Limited (PBL) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued out US Patent No. 8,097,710 with fundamental claims directed to methods of inducing gene silencing using short RNA molecules, or DNA constructs encoding short RNA molecules, in a wide range of organisms, including in plants and humans.
› Verified 6 days ago